5.46 - 5.56
4.95 - 8.28
1.3K / 2.4K (Avg.)
-277.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.66%
Negative revenue growth while STERV.HE stands at 1.98%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-0.66%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
194.23%
EBIT growth above 1.5x STERV.HE's 17.19%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
194.23%
Operating income growth above 1.5x STERV.HE's 17.19%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
127.94%
Net income growth 1.25-1.5x STERV.HE's 113.24%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
128.57%
EPS growth at 75-90% of STERV.HE's 160.00%. Bill Ackman would push for improved profitability or share repurchases to catch up.
128.57%
Diluted EPS growth at 75-90% of STERV.HE's 160.00%. Bill Ackman would expect further improvements in net income or share count reduction.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-204.88%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-292.31%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
1.13%
Positive 10Y revenue/share CAGR while STERV.HE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
1.13%
Positive 5Y CAGR while STERV.HE is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
1.13%
Positive 3Y CAGR while STERV.HE is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-542.92%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-542.92%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-542.92%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
117.29%
Positive 10Y CAGR while STERV.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
117.29%
5Y net income/share CAGR 1.25-1.5x STERV.HE's 79.36%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
117.29%
Positive short-term CAGR while STERV.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.77%
Inventory growth well above STERV.HE's 3.99%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-6.29%
Negative asset growth while STERV.HE invests at 4.11%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.46%
BV/share growth above 1.5x STERV.HE's 1.61%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-17.87%
We’re deleveraging while STERV.HE stands at 6.08%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.